BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 20133740)

  • 1. Delivery of foreign antigens by engineered outer membrane vesicle vaccines.
    Chen DJ; Osterrieder N; Metzger SM; Buckles E; Doody AM; DeLisa MP; Putnam D
    Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3099-104. PubMed ID: 20133740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered bacterial outer membrane vesicles with enhanced functionality.
    Kim JY; Doody AM; Chen DJ; Cremona GH; Shuler ML; Putnam D; DeLisa MP
    J Mol Biol; 2008 Jun; 380(1):51-66. PubMed ID: 18511069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered Bacterial Outer Membrane Vesicles with Lipidated Heterologous Antigen as an Adjuvant-Free Vaccine Platform for Streptococcus suis.
    Li Q; Zhou G; Fei X; Tian Y; Wang S; Shi H
    Appl Environ Microbiol; 2023 Mar; 89(3):e0204722. PubMed ID: 36809058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic insight into the TH1-biased immune response to recombinant subunit vaccines delivered by probiotic bacteria-derived outer membrane vesicles.
    Rosenthal JA; Huang CJ; Doody AM; Leung T; Mineta K; Feng DD; Wayne EC; Nishimura N; Leifer C; DeLisa MP; Mendez S; Putnam D
    PLoS One; 2014; 9(11):e112802. PubMed ID: 25426709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Employing Escherichia coli-derived outer membrane vesicles as an antigen delivery platform elicits protective immunity against Acinetobacter baumannii infection.
    Huang W; Wang S; Yao Y; Xia Y; Yang X; Li K; Sun P; Liu C; Sun W; Bai H; Chu X; Li Y; Ma Y
    Sci Rep; 2016 Nov; 6():37242. PubMed ID: 27849050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineered outer membrane vesicle is potent to elicit HPV16E7-specific cellular immunity in a mouse model of TC-1 graft tumor.
    Wang S; Huang W; Li K; Yao Y; Yang X; Bai H; Sun W; Liu C; Ma Y
    Int J Nanomedicine; 2017; 12():6813-6825. PubMed ID: 28979120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of
    Croia L; Boscato Sopetto G; Zanella I; Caproni E; Gagliardi A; Tamburini S; König E; Benedet M; Di Lascio G; Corbellari R; Grandi A; Tomasi M; Grandi G
    Membranes (Basel); 2023 Nov; 13(11):. PubMed ID: 37999368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial outer membrane vesicles engineered with lipidated antigens as a platform for
    Irene C; Fantappiè L; Caproni E; Zerbini F; Anesi A; Tomasi M; Zanella I; Stupia S; Prete S; Valensin S; König E; Frattini L; Gagliardi A; Isaac SJ; Grandi A; Guella G; Grandi G
    Proc Natl Acad Sci U S A; 2019 Oct; 116(43):21780-21788. PubMed ID: 31591215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the Escherichia coli toxin cytolysin A on mucosal immunostimulation via epithelial Ca2+ signalling and Toll-like receptor 4.
    Söderblom T; Oxhamre C; Wai SN; Uhlén P; Aperia A; Uhlin BE; Richter-Dahlfors A
    Cell Microbiol; 2005 Jun; 7(6):779-88. PubMed ID: 15888081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-mediated immunity induced by engineered Escherichia coli OMVs carrying heterologous antigens in their lumen.
    Fantappiè L; de Santis M; Chiarot E; Carboni F; Bensi G; Jousson O; Margarit I; Grandi G
    J Extracell Vesicles; 2014; 3():. PubMed ID: 25147647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robust Immune Response Induced by
    Barbosa MMF; Kanno AI; Barazzone GC; Rodriguez D; Pancakova V; Trentini M; Faquim-Mauro EL; Freitas AP; Khouri MI; Lobo-Silva J; Goncalves VM; Schenkman RPF; Tanizaki MM; Boraschi D; Malley R; Farias LP; Leite LCC
    Int J Nanomedicine; 2021; 16():7153-7168. PubMed ID: 34712047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering probiotic-derived outer membrane vesicles as functional vaccine carriers to enhance immunity against SARS-CoV-2.
    Wo J; Lv ZY; Sun JN; Tang H; Qi N; Ye BC
    iScience; 2023 Jan; 26(1):105772. PubMed ID: 36510593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designer outer membrane vesicles as immunomodulatory systems - Reprogramming bacteria for vaccine delivery.
    Gnopo YMD; Watkins HC; Stevenson TC; DeLisa MP; Putnam D
    Adv Drug Deliv Rev; 2017 May; 114():132-142. PubMed ID: 28501509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vesicle-mediated export and assembly of pore-forming oligomers of the enterobacterial ClyA cytotoxin.
    Wai SN; Lindmark B; Söderblom T; Takade A; Westermark M; Oscarsson J; Jass J; Richter-Dahlfors A; Mizunoe Y; Uhlin BE
    Cell; 2003 Oct; 115(1):25-35. PubMed ID: 14532000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptation of the endogenous Salmonella enterica serovar Typhi clyA-encoded hemolysin for antigen export enhances the immunogenicity of anthrax protective antigen domain 4 expressed by the attenuated live-vector vaccine strain CVD 908-htrA.
    Galen JE; Zhao L; Chinchilla M; Wang JY; Pasetti MF; Green J; Levine MM
    Infect Immun; 2004 Dec; 72(12):7096-106. PubMed ID: 15557633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative Evaluation of Recombinant Protein Packaged into Outer Membrane Vesicles of Escherichia coli Cells.
    Ojima Y; Yamaguchi K; Taya M
    Biotechnol Prog; 2018 Jan; 34(1):51-57. PubMed ID: 28786214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Display of Recombinant Proteins on Bacterial Outer Membrane Vesicles by Using Protein Ligation.
    van den Berg van Saparoea HB; Houben D; de Jonge MI; Jong WSP; Luirink J
    Appl Environ Microbiol; 2018 Apr; 84(8):. PubMed ID: 29439988
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Quan K; Zhu Z; Cao S; Zhang F; Miao C; Wen X; Huang X; Wen Y; Wu R; Yan Q; Huang Y; Ma X; Han X; Zhao Q
    J Microbiol Biotechnol; 2018 Dec; 28(12):2095-2105. PubMed ID: 30380823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8
    Schetters STT; Jong WSP; Horrevorts SK; Kruijssen LJW; Engels S; Stolk D; Daleke-Schermerhorn MH; Garcia-Vallejo J; Houben D; Unger WWJ; den Haan JMM; Luirink J; van Kooyk Y
    Acta Biomater; 2019 Jun; 91():248-257. PubMed ID: 31003032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A "Plug-and-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-binding Domain.
    Feng R; Li GC; Jing HM; Liu C; Xue RY; Zou QM; Li HB
    J Vis Exp; 2022 Jul; (185):. PubMed ID: 35938846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.